vimarsana.com
Home
Live Updates
Second-Generation Monarch eTNS System Cleared for Pediatric
Second-Generation Monarch eTNS System Cleared for Pediatric
Second-Generation Monarch eTNS System Cleared for Pediatric ADHD
The FDA has cleared NeuroSigma’s second-generation Monarch eTNS System to treat ADHD in patients 7 to 12 years of age.
Related Keywords
London ,
City Of ,
United Kingdom ,
Colin Kealey ,
King College London ,
Drug Administration ,
Trigeminal Nerve Stimulation ,
Clinical Global Impression ,
Seattle Children ,
College London ,